2/3
08:00 am
mgtx
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
Low
Report
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
2/3
07:12 am
mgtx
MeiraGTx (NASDAQ:MGTX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
MeiraGTx (NASDAQ:MGTX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/28
01:07 pm
mgtx
Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership [Yahoo! Finance]
Low
Report
Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership [Yahoo! Finance]
1/2
08:44 am
mgtx
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors [Seeking Alpha]
Medium
Report
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors [Seeking Alpha]
11/25
07:31 am
mgtx
MeiraGTx (NASDAQ:MGTX) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
MeiraGTx (NASDAQ:MGTX) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
11/24
07:02 am
mgtx
MeiraGTx (NASDAQ:MGTX) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Low
Report
MeiraGTx (NASDAQ:MGTX) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
11/20
03:00 pm
mgtx
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
Low
Report
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
11/14
09:05 am
mgtx
MeiraGTx (NASDAQ:MGTX) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
MeiraGTx (NASDAQ:MGTX) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/13
08:00 am
mgtx
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
Low
Report
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
11/12
12:09 pm
mgtx
Senate Punts On Health Insurance Subsidies To End Shutdown [Forbes]
Medium
Report
Senate Punts On Health Insurance Subsidies To End Shutdown [Forbes]
11/11
12:49 pm
mgtx
MeiraGTx (NASDAQ:MGTX) had its price target raised by analysts at Piper Sandler from $28.00 to $30.00. They now have an "overweight" rating on the stock.
Low
Report
MeiraGTx (NASDAQ:MGTX) had its price target raised by analysts at Piper Sandler from $28.00 to $30.00. They now have an "overweight" rating on the stock.
11/11
08:08 am
mgtx
MeiraGTx (NASDAQ:MGTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $35.00 price target on the stock.
Medium
Report
MeiraGTx (NASDAQ:MGTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $35.00 price target on the stock.